Global Human Microbiome Sequencing Market is expected to grow at an 20.7% CAGR during the forecast period for 2024-2031.
Global Human Microbiome Sequencing Market is expected to grow at an 20.7% CAGR during the forecast period for 2024-2031.
Microbial communities that exist in a variety of environments, including the human body, are analyzed as part of microbiome sequencing services. These are specialist techniques created to recognize and examine the various microorganisms that inhabit a specific habitat, including the human gut, soil, or water. The genetic material of microbes is decoded using sophisticated deoxyribonucleic acid (DNA) sequencing technology, enabling researchers and medical professionals to comprehend the makeup, diversity, and roles of these microbial communities.
The global demand for microbiome sequencing services to study host-pathogen connections is expanding due to an increase in the prevalence of infectious diseases among the general public. Furthermore, the market is expanding due to the growing trend of microbiome-based therapies, such as fecal microbiota transplantation (FMT), which depends on precise microbiome profiling for treatment efficacy and safety.
Download Free Report Sample Pages: https://www.insightaceanalytic.com/request-sample/1380
In addition, the industry is being positively impacted by the increasing use of microbiome sequencing in veterinary care to better understand animal health, prevent disease, and increase livestock productivity. Furthermore, the growth of the pharmaceutical sector is propelling the use of microbiome data to create new medications, especially for gastrointestinal disorders, which is boosting the market.
Recent Developments:
- In March 2024, BIOHM Health Inc, collaborate with Virginia Tech to rapidly developed and commercialized products based on bacterial and fungal microbiomes using Artificial Intelligence.
- In April 2024, Seed health, the company introduced CODA, a revolutionary computational biology platform that finds and develops next-generation precision probiotics and microbiome-directed therapies using AI and machine learning. The platform applies knowledge from the 200 terabytes of human data in the multi-omic Human Phenotype Project to improve menopause, longevity, brain health, and metabolic health.
List of Prominent Players in the Global Human Microbiome Sequencing Market:
- Baseclear B.V.,
- Beijing Genomics Institute (BGI) Genomics Co., Ltd,
- Charles River Laboratories International Inc.,
- Clinical Microbiomics A/S,
- Eurofins Scientific SE,
- GENEWIZ, Inc.,
- Illumina, Inc.,
- Novogene Corporation,
- OraSure Technologies, Inc.,
- Oxford Nanopore Technologies, Inc.,
- Pacific Biosciences of California, Inc.,
- QIAGEN N.V.,
- Second Genome, Inc.,
- Thermo Fisher Scientific Inc.,
- Viome, Inc.,
- CosmosID,
- Leucine Rich Bio Pvt. Ltd.,
- Microba,
- Microbiome Insights Inc.,
- Molzym GmbH & Co. KG.
Market Dynamics:
Drivers:
Large investments in microbiome research, an increase in the need for NGS services like whole genome sequencing, exome sequencing, targeted sequencing, etc., an increase in genomic research, and the expanding field of applications for microbiome sequencing are the main drivers of market expansion.
The market for microbiome sequencing is expanding due in large part to the rising demand for Next-Generation Sequencing. In April 2022, for instance, an article in the Journal of Clinical Investigation revealed that next-generation sequencing (NGS) technology has improved understanding of the human microbiome by making it possible to identify and characterize unculturable microbes and predict their function. The market for next-generation microbiome sequencing is anticipated to increase at a faster rate as a result of these innovations.
Challenges:
Growth in the market is anticipated to be hampered by the high cost of research and development capabilities, inadequate research on the human microbiome, and limited infrastructure. In addition, obstacles to establishing the causal relationship between dysbiosis and diseases, inadequate infrastructure in low- and middle-income nations, unfavorable reimbursement scenarios, and technology penetration in developing economies are anticipated to pose challenges to the market during the forecast period.
Regional Trends:
The market in North America is anticipated to develop at a faster rate due to the increasing use of highly sophisticated systems and techniques in microbiome sequencing services as well as technical advancements in genomic research projects.
The market for microbiome sequencing is expanding as a result of the growing number of cancer cases in the North American region. Over the course of the projection period. Significant growth is predicted for Asia-Pacific. because of the growth of medical tourism, government awareness-raising initiatives, the expansion of local research projects, the rise in autoimmune disorders and other lifestyle-related ailments, and the local population’s growing need for high-quality healthcare.
Segmentation of Global Human Microbiome Sequencing Market –
Global Human Microbiome Sequencing Market – By Product
- Kits and Assays
- Instruments
- Software
Global Human Microbiome Sequencing Market – By Technology
- Next-generation Sequencing
- Sequencing by Synthesis
- Sequencing by Ligation
- Other Next-Generation Sequencing Technologies
- Traditional Sequencing Technologies
- Pyrosequencing
- Sanger Sequencing
- Other Sequencing Technology
Global Human Microbiome Sequencing Market – By Application
- Disease Diagnosis
- Gastrointestinal Diseases
- Metabolic Diseases
- Oncology
- Infectious Diseases
- Neurological Diseases
- Other Diseases
- Drug Discovery
- Consumer Wellness
- Omics Analysis
- Genome Analysis
- Metabolome Analysis
- Transcriptome Analysis
- Other Omics Analysis
- Other application
Global Human Microbiome Sequencing Market – By End-User
- Academic and Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Global Human Microbiome Sequencing Market – By Region
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Order the 180 Pages Detailed Report @ https://www.insightaceanalytic.com/buy-report/1380
Call: North America +1 551 226 6109 Email: diana.dsouza@insightaceanalytics.com